D68.32 – Hemorrhagic disorder due to extrinsic circulating anticoagulants
Coding Notes
Active
Billable, valid for HIPAA-covered transactions
Additional
code for adverse effect, if applicable, to identify drug (T45.515, T45.525)
Applicable To
Drug-induced hemorrhagic disorder
Hemorrhagic disorder due to increase in anti-IIa
Hemorrhagic disorder due to increase in anti-Xa
Hyperheparinemia
GEM Conversion to ICD-9 CM
Fs: 10000
–
Acquired coagulation factor deficiency
MDC / MS-DRG Reference
Back Reference of Diagnostic Codes
Sibling Codes
Parent Sibling Codes
View in Tabular
Code | Title |
---|---|
D50-D89 | Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) |
D65-D69 | Coagulation defects, purpura and other hemorrhagic conditions (D65-D69) |
D68 | Other coagulation defects |
D68.3 | Hemorrhagic disorder due to circulating anticoagulants |
D68.32 |
Hemorrhagic disorder due to extrinsic circulating anticoagulants
Use Additional
code for adverse effect, if applicable, to identify drug (T45.515, T45.525)
Applicable to
Drug-induced hemorrhagic disorder
Hemorrhagic disorder due to increase in anti-IIa
Hemorrhagic disorder due to increase in anti-Xa
Hyperheparinemia
|